Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

Clin Cancer Res (2007) 13 (12): 3552–3558.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial
  • Lucia Zanoni
  • Alessandro Broccoli
  • Alessandro Lambertini
  • Cinzia Pellegrini
  • Vittorio Stefoni
  • Filippo Lodi
  • Cristina Fonti
  • Cristina Nanni
  • Pier Luigi Zinzani
  • Stefano Fanti
European Journal of Nuclear Medicine and Molecular Imaging (2019) 46 (8): 1661.
3′-Deoxy-3’-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies
  • Jeong Eun Kim
  • Sun Young Chae
  • Jwa Hoon Kim
  • Hwa Jung Kim
  • Tae Won Kim
  • Kyu-pyo Kim
  • Sun Young Kim
  • Jae-Lyun Lee
  • Seung Jun Oh
  • Jae Seung Kim
  • Jin-Sook Ryu
  • Dae Hyuk Moon
  • Yong Sang Hong
European Journal of Nuclear Medicine and Molecular Imaging (2019) 46 (8): 1713.
18F-FDG and 11C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study
  • Ryogo Minamimoto
  • Yuichiro Takeda
  • Masatoshi Hotta
  • Jun Toyohara
  • Kazuhiko Nakajima
  • Go Naka
  • Haruhito Sugiyama
EJNMMI Research (2019) 9 (1)
Imaging Potential Evaluation of Fab Derived from the Anti-EGFRvIII Monoclonal Antibody 4G1
  • Shen Jing
  • Yujia He
  • Yanqiong He
  • Liang Wang
  • Jianhua Jia
  • Xiaomin Shan
  • Shuang Liu
  • Min Tang
  • Zhiping Peng
  • Xujie Liu
Radiation Research (2018) 190 (2): 194.
Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response
  • Victor H. Gerbaudo
  • Joseph H. Killoran
  • Chun K. Kim
  • Jason L. Hornick
  • Jonathan A. Nowak
  • Peter C. Enzinger
  • Harvey J. Mamon
Annals of Nuclear Medicine (2018) 32 (3): 165.
Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging
  • C. Sachpekidis
  • H. Goldschmidt
  • K. Kopka
  • A. Kopp-Schneider
  • A. Dimitrakopoulou-Strauss
EJNMMI Research (2018) 8 (1)
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
  • Hinrich Wieder
  • Ambros J. Beer
  • Jens Siveke
  • Tibor Schuster
  • Andreas K. Buck
  • Ken Herrmann
  • Jens C. Stollfuss
Oncotarget (2018) 9 (11): 10128.
A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery
  • Masatoyo Nakajo
  • Yoriko Kajiya
  • Atsushi Tani
  • Megumi Jinguji
  • Masayuki Nakajo
  • Masaki Kitazono
  • Takashi Yoshiura
European Journal of Nuclear Medicine and Molecular Imaging (2017) 44 (13): 2158.
A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT
  • Masatoyo Nakajo
  • Yoriko Kajiya
  • Atsushi Tani
  • Megumi Jinguji
  • Masayuki Nakajo
  • Tohru Nihara
  • Yoshihiko Fukukura
  • Takashi Yoshiura
Abdominal Radiology (2017) 42 (4): 1210.
Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts
  • Xujie Liu
  • Chengyan Dong
  • Jiyun Shi
  • Teng Ma
  • Zhongxia Jin
  • Bing Jia
  • Zhaofei Liu
  • Li Shen
  • Fan Wang
Oncotarget (2017) 8 (4): 6364.
Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma
  • Martin A. Lodge
  • Matthias Holdhoff
  • Jeffrey P. Leal
  • Asim K. Bag
  • L. Burt Nabors
  • Akiva Mintz
  • Glenn J. Lesser
  • David A. Mankoff
  • Arati S. Desai
  • James M. Mountz
  • Frank S. Lieberman
  • Joy D. Fisher
  • Serena Desideri
  • Xiaobu Ye
  • Stuart A. Grossman
  • David Schiff
  • Richard L. Wahl
Journal of Nuclear Medicine (2017) 58 (3): 393.
The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy
  • Chenchen Wang
  • Weijian Guo
  • Min Zhou
  • Xiaodong Zhu
  • Dongmei Ji
  • Wenhua Li
  • Xin Liu
  • Zhonghua Tao
  • Xiaowei Zhang
  • Yingjian Zhang
  • Jin Li
Clinical Cancer Research (2016) 22 (7): 1603.
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring
  • Ryogo Minamimoto
  • Luis Fayad
  • Ranjana Advani
  • Julie Vose
  • Homer Macapinlac
  • Jane Meza
  • Jordan Hankins
  • Felix Mottaghy
  • Malik Juweid
  • Andrew Quon
Radiology (2016) 280 (1): 220.
A method for quantitative total marrow imaging (QTMI) with PET/CT
  • Timothy G Perk
  • Natalie A Weisse
  • Stephen S F Yip
  • Robert Jeraj
Biomedical Physics & Engineering Express (2016) 2 (5): 055006.
A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients
  • V.R. Bollineni
  • G.M. Kramer
  • E.P. Jansma
  • Y. Liu
  • W.J.G. Oyen
European Journal of Cancer (2016) 55: 81.
Prognostic Value Comparison Between 18F-FLT PET/CT and 18F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Head and Neck Cancer
  • Hiroshi Hoshikawa
  • Terushige Mori
  • Yuka Yamamoto
  • Takehito Kishino
  • Takashi Fukumura
  • Yasushi Samukawa
  • Nozomu Mori
  • Yoshihiro Nishiyama
Clinical Nuclear Medicine (2015) 40 (6): 464.
Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
  • Robert Jeraj
  • Tyler Bradshaw
  • Urban Simončič
Journal of Nuclear Medicine (2015) 56 (11): 1752.
Preclinical Evaluation of CD40-Directed Immunotherapy in B-Cell Lymphoma Using [<sup>18</sup>F]Fluorothymidine-PET
  • Nicolas Graf
  • Zhoulei Li
  • Ken Herrmann
  • Michaela Aichler
  • Jolanta Slawska
  • Axel Walch
  • Christian Peschel
  • Markus Schwaiger
  • Andreas K. Buck
  • Tobias Dechow
  • Ulrich Keller
Advances in Molecular Imaging (2015) 05 (02): 17.
Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
  • Stefanie M. F. Seiler
  • Christine Baumgartner
  • Johannes Hirschberger
  • Ambros J. Beer
  • Andreas Brühschwein
  • Nina Kreutzmann
  • Silja Laberke
  • Melanie C. Wergin
  • Andrea Meyer-Lindenberg
  • Johanna Brandl
  • Anne-Kathrin von Thaden
  • Eliane Farrell
  • Markus Schwaiger
  • Ramasamy Paulmurugan
PLOS ONE (2015) 10 (6): e0127800.
Predictive value of SUV-based parameters derived from pre-treatment 18F-FLT PET/CT for short-term outcome with head and neck cancers
  • Hiroshi Hoshikawa
  • Yuka Yamamoto
  • Terushige Mori
  • Takehito Kishino
  • Takashi Fukumura
  • Yasushi Samukawa
  • Nozomu Mori
  • Yoshihiro Nishiyama
Annals of Nuclear Medicine (2014) 28 (10): 1020.
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL
  • Ken Herrmann
  • Andreas K. Buck
  • Tibor Schuster
  • Kathrin Abbrederis
  • Christina Blümel
  • Ivan Santi
  • Martina Rudelius
  • Hans-Jürgen Wester
  • Christian Peschel
  • Markus Schwaiger
  • Tobias Dechow
  • Ulrich Keller
Oncotarget (2014) 5 (12): 4050.
Proliferation Imaging with 18F-Fluorothymidine PET/Computed Tomography
  • Ken Herrmann
  • Andreas K. Buck
PET Clinics (2014) 9 (3): 331.
18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
  • Marielle J Wondergem
  • Ken Herrmann
  • Sergei Syrbu
  • Josée M Zijlstra
  • Nikie Hoetjes
  • Otto S Hoekstra
  • Saskia AGM Cillessen
  • Laura M Moesbergen
  • Andreas K Buck
  • Julie M Vose
  • Malik E Juweid
EJNMMI Research (2014) 4 (1): 3.
Early Determination of Prognosis by Interim 3′-Deoxy-3′-18F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma
  • Hyewon Lee
  • Seok-ki Kim
  • Yong-il Kim
  • Tae Sung Kim
  • Se Hun Kang
  • Weon Seo Park
  • Tak Yun
  • Hyeon-Seok Eom
Journal of Nuclear Medicine (2014) 55 (2): 216.
PET/CT imaging in cancer: Current applications and future directions
  • Michael D. Farwell
  • Daniel A. Pryma
  • David A. Mankoff
Cancer (2014) 120 (22): 3433.
Positron emission tomography/CT in the management of lymphoma
  • A V MARTIN
  • D CUNNINGHAM
  • B SHARMA
Imaging (2013) 22 (1): 20110086.
18F-Fluorothymidine PET Is a Potential Predictive Imaging Biomarker of the Response to Gemcitabine-Based Chemotherapeutic Treatment for Recurrent Ovarian Cancer
  • Hideaki Tsuyoshi
  • Fumiko Morishita
  • Makoto Orisaka
  • Hidehiko Okazawa
  • Yoshio Yoshida
Clinical Nuclear Medicine (2013) 38 (7): 560.
Changes in 18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy
  • Hiroshi Hoshikawa
  • Terushige Mori
  • Takehito Kishino
  • Yuka Yamamoto
  • Ryuhei Inamoto
  • Kosuke Akiyama
  • Nozomu Mori
  • Yoshihiro Nishiyama
Annals of Nuclear Medicine (2013) 27 (4): 363.
Assessment of early changes in 3H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression
  • Songji Zhao
  • Yuji Kuge
  • Yan Zhao
  • Satoshi Takeuchi
  • Kenji Hirata
  • Toshiki Takei
  • Tohru Shiga
  • Hirotoshi Dosaka-Akita
  • Nagara Tamaki
BMC Cancer (2013) 13 (1)
Update on Pediatric Leukemia and Lymphoma Imaging
  • Lauren W. Averill
  • Gunsel Acikgoz
  • Robin E. Miller
  • Vinay V.R. Kandula
  • Monica Epelman
Seminars in Ultrasound, CT and MRI (2013) 34 (6): 578.
Managing Lymphoma with Non-FDG Radiotracers: Current Clinical and Preclinical Applications
  • Fan-Lin Kong
  • Richard J. Ford
  • David J. Yang
BioMed Research International (2013) 2013: 1.
The role of F-18-fluorothymidine PET in oncology
  • Francesco Bertagna
  • Giorgio Biasiotto
  • Raffaele Giubbini
Clinical and Translational Imaging (2013) 1 (2): 77.
Introduction to the analysis of PET data in oncology
  • Giampaolo Tomasi
  • Eric O. Aboagye
Journal of Pharmacokinetics and Pharmacodynamics (2013) 40 (4): 419.
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner
  • Nicolas Graf
  • Ken Herrmann
  • Barbara Numberger
  • Daniela Zwisler
  • Michaela Aichler
  • Annette Feuchtinger
  • Tibor Schuster
  • Hans-Jürgen Wester
  • Reingard Senekowitsch-Schmidtke
  • Christian Peschel
  • Markus Schwaiger
  • Ulrich Keller
  • Tobias Dechow
  • Andreas K. Buck
European Journal of Nuclear Medicine and Molecular Imaging (2013) 40 (1): 34.
18F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns
  • Sanjay Chandrasekaran
  • Andrew Hollander
  • Xiangsheng Xu
  • Joseph L. Benci
  • James J. Davis
  • Jay F. Dorsey
  • Gary Kao
The Scientific World Journal (2013) 2013: 1.
PET Imaging of Proliferation with Pyrimidines
  • Omid S. Tehrani
  • Anthony F. Shields
Journal of Nuclear Medicine (2013) 54 (6): 903.
Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response
  • Matt Vanderhoek
  • Scott B. Perlman
  • Robert Jeraj
Journal of Nuclear Medicine (2012) 53 (1): 4.
Positron Emission Tomographic Scans in Lymphoma: Convention and Controversy
  • Stephen M. Ansell
  • James O. Armitage
Mayo Clinic Proceedings (2012) 87 (6): 571.
PET imaging: implications for the future of therapy monitoring with PET/CT in oncology
  • Giampaolo Tomasi
  • Lula Rosso
Current Opinion in Pharmacology (2012) 12 (5): 569.
Comparison of18F-FLT PET and18F-FDG PET for detection of cervical lymph node metastases in head and neck cancers
  • Hiroshi Hoshikawa
  • Takehito Kishino
  • Terushige Mori
  • Yoshihiro Nishiyama
  • Yuka Yamamoto
  • Ryuhei Inamoto
  • Kosuke Akiyama
  • Nozomu Mori
Acta Oto-Laryngologica (2012) 132 (12): 1347.
Hitting the target in MCL
  • Michael Crump
Blood (2012) 119 (20): 4580.
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy
  • M. Christina Cox
  • Vincenzo Ambrogi
  • Valerio Lanni
  • Elena Cavalieri
  • Sabrina Pelliccia
  • Francesco Scopinaro
  • Bruno Monarca
  • Paolo Marchetti
  • M. Antonietta Aloe Spiriti
Leukemia & Lymphoma (2012) 53 (2): 263.
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
  • Violaine Safar
  • Jehan Dupuis
  • Emmanuel Itti
  • Fabrice Jardin
  • Christophe Fruchart
  • Stéphane Bardet
  • Pierre Véra
  • Christiane Copie-Bergman
  • Alain Rahmouni
  • Hervé Tilly
  • Michel Meignan
  • Corinne Haioun
Journal of Clinical Oncology (2012) 30 (2): 184.
Usefulness of 3′-Deoxy-3′-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer
  • Takehito Kishino
  • Hiroshi Hoshikawa
  • Yoshihiro Nishiyama
  • Yuka Yamamoto
  • Nozomu Mori
Journal of Nuclear Medicine (2012) 53 (10): 1521.
Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future
  • Giampaolo Tomasi
  • Federico Turkheimer
  • Eric Aboagye
Molecular Imaging and Biology (2012) 14 (2): 131.
3′-deoxy-3′-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma
  • Matthias R. Benz
  • Johannes Czernin
  • Martin S. Allen-Auerbach
  • Sarah M. Dry
  • Piriya Sutthiruangwong
  • Claudio Spick
  • Caius Radu
  • Wolfgang A. Weber
  • William D. Tap
  • Fritz C. Eilber
Cancer (2012) 118 (12): 3135.
Novel PET Radiotracers for Potential Use in Management of Lymphoma
  • Lale Kostakoglu
PET Clinics (2012) 7 (1): 83.
FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy
  • Zhoulei Li
  • Nicolas Graf
  • Ken Herrmann
  • Alexandra Jünger
  • Michaela Aichler
  • Annette Feuchtinger
  • Anja Baumgart
  • Axel Walch
  • Christian Peschel
  • Markus Schwaiger
  • Andreas Buck
  • Ulrich Keller
  • Tobias Dechow
Cancer Research (2012) 72 (19): 5014.
[18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment
  • Dmitry Soloviev
  • David Lewis
  • Davina Honess
  • Eric Aboagye
European Journal of Cancer (2012) 48 (4): 416.
The Feasibility of 18F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer
  • Seol Hoon Park
  • Jin-Sook Ryu
  • Seung-Jun Oh
  • Seung-Il Park
  • Yong Hee Kim
  • Hoon-Yong Jung
  • Gin Hyug Lee
  • Ho Jun Song
  • Jong Hoon Kim
  • Ho-Young Song
  • Kyoung Ja Cho
  • Sung-Bae Kim
Nuclear Medicine and Molecular Imaging (2012) 46 (1): 57.
  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2022 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept